Evidence map›Paper›PMID 28402411›Full record

ArticleCardiovascular research2017

Impact of acute hypertension transients on diastolic function in patients with heart failure with preserved ejection fraction.

Candelas Pérez Del Villar, Konstantinos Savvatis, Begoña López, Mario Kasner, Pablo Martinez-Legazpi, Raquel Yotti, Arantxa González, Javier Díez, Francisco Fernández-Avilés, Carsten Tschöpe and 1 more

Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Cardiovascular research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04739215 (Effects of Sodium-Glucose Cotransporter 2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With Heart Failure With Preserved Ejection Fraction), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04739215 phase4unknown statusstarted 2021, after this paper: background citation

Effects of Sodium-Glucose Cotransporter 2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With Heart Failure With Preserved Ejection Fraction

Ran2021Enrolled62Registered outcomes10Posted comparisons0ConditionsDiabetes Mellitus, Type 2, Heart Failure With Preserved Ejection FractionArmsDapagliflozin 10 MG [Farxiga], Placebo
PMID 26378978PMID 23743396PMID 21329845other papers from this trial
Open the trial in the graph
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Blood pressure changes during routine transthoracic echocardiography.International journal of cardiology. Cardiovascular risk and prevention · 2023
    Article
  7. Article
  8. Review
  9. Review
  10. Cardiac fibrosis.Cardiovascular research · 2021
    Review
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Candelas Pérez Del VillarDepartment of Cardiology, Hospital General Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón, and CIBERCV, Dr. Esquerdo 46, 28007 Madrid, Spain.
Konstantinos SavvatisDepartment of Cardiology, Barts Heart Centre, Queen Mary University of London, London EC1A 7BE, UK.
Begoña LópezProgram of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, IdiSNA, Navarra Institute for Health Research, and CIBERCV, Pío XII 55, 31008 Pamplona, Spain.
Mario KasnerDepartment of Cardiology, Charité University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany.
Pablo Martinez-LegazpiDepartment of Cardiology, Hospital General Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón, and CIBERCV, Dr. Esquerdo 46, 28007 Madrid, Spain.
Raquel YottiDepartment of Cardiology, Hospital General Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón, and CIBERCV, Dr. Esquerdo 46, 28007 Madrid, Spain.
Arantxa GonzálezProgram of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, IdiSNA, Navarra Institute for Health Research, and CIBERCV, Pío XII 55, 31008 Pamplona, Spain.
Javier DíezProgram of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, IdiSNA, Navarra Institute for Health Research, and CIBERCV, Pío XII 55, 31008 Pamplona, Spain.
Francisco Fernández-AvilésDepartment of Cardiology, Hospital General Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón, and CIBERCV, Dr. Esquerdo 46, 28007 Madrid, Spain.
Carsten TschöpeBerlin-Brandenburg Centre for Regenerative Therapies, Föhrer Str. 15, 13353 Berlin, Germany.
Javier BermejoDepartment of Cardiology, Hospital General Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón, and CIBERCV, Dr. Esquerdo 46, 28007 Madrid, Spain.
Centro de Investigación en Red en Enfermedades Cardiovasculares · ESBerlin-Brandenburger Centrum für Regenerative Therapien · DECharité - Universitätsmedizin Berlin · DEGerman Centre for Cardiovascular Research · DEHospital General Universitario Gregorio Marañón · ESUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo address the mechanisms responsible for the increase in LV filling pressures induced by acute hypertension transients in patients with heart failure with preserved ejection fraction (HFpEF). METHODS AND

resultsMultiple-beat pressure-volume loops were recorded during inferior vena cava occlusion in 39 HFpEF patients and 20 controls during handgrip and atrial pacing. We measured the contribution of relaxation, elastic recoil, and stiffness to instantaneous diastolic pressure using a novel processing method. Fibrosis was quantified from endomyocardial biopsies. HFpEF patients showed higher diastolic pressures and stiffness constant than controls (P < 0.05 for all). As opposed to controls, all intrinsic global diastolic properties were sensitive to acute changes in systolic pressure in the HFpEF group. In fact, the stiffness constant increased by more than 50% during handgrip in HFpEF patients (P < 0.05), tightly related to changes in systolic pressure (fixed-effect = 0.26 mm Hg per mm Hg [95% CI = 0.15-0.37]; P < 0.0001). Incomplete relaxation contributed to increasing pressure before atrial contraction, but changes in end-diastolic pressure was mostly caused by the increase in stiffness. The degree of pressure-sensitivity of stiffness correlated with myocardial collagen volume and crosslinking (R = 0.40 to 0.82 for all).

conclusionAcute chamber stiffening is the main mechanism responsible for rising late-diastolic pressures when HFpEF patients undergo hypertension transients. This stiffening behaviour is related to impaired dynamic systolic-diastolic interactions and correlates with matrix remodelling. Ventricular-vascular relationships are a promising target in HFpEF and should be taken into account when assessing diastolic function.

Indexed as

AdultAgedDiastoleFemaleHand StrengthHeart FailureHumansHypertensionMaleMiddle AgedStroke VolumeVentricular Dysfunction, LeftDiastolic functionDiastolic stiffnessHeart failureHypertensionLeft ventricle

Identifiers

PMID28402411
OpenAlexW2605728656

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.